Toll-like receptor-4 pathway as a possible molecular mechanism for brain injuries after subarachnoid hemorrhage

References

• Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013; 44(7):2064–2089.
   PubMed Web of Science ®Google Scholar
• Venti M. Subarachnoid and intraventricular hemorrhage. Front Neurol Neurosci. 2012;30:149–153.
   PubMedGoogle Scholar
• Inagawa T. Risk factors for the formation and rupture of intracranial saccular aneurysms in Shimane, Japan. World Neurosurg. 2010;73(3):155–164. Discussion e23.
   PubMed Web of Science ®Google Scholar
• Chen S, Feng H, Sherchan P, et al. Controversies and evolving new mechanisms in subarachnoid hemorrhage. Prog Neurobiol. 2014;115:64–91.
   PubMed Web of Science ®Google Scholar
• Dinc N, Won S-Y, Quick-Weller J, et al. Prognostic variables and outcome in relation to different bleeding patterns in arteriovenous malformations. Neurosurg Rev. 2019;42(3):731–736.
   PubMed Web of Science ®Google Scholar
• Chen H, Hou K, Wang X, et al. Spontaneous recession of a posterior cerebral artery aneurysm concurrent with carotid rete mirabile and moyamoya-pattern collateral vessels: a case report. BMC Neurol. 2019;19(1):51.
   PubMed Web of Science ®Google Scholar
• Nakaya M, Hashimoto H, Usui G, et al. Cerebral amyloid-beta-related angiitis without cerebral microbleeds in a patient with subarachnoid hemorrhage. Cardiovasc Pathol. 2019;42:36–40.
   PubMed Web of Science ®Google Scholar
• Cabral KP, Fraser GL, Duprey J, et al. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding. Clin Neurol Neurosurg. 2013;115(6):770–774.
   PubMed Web of Science ®Google Scholar
• Papathanasiou A, Zouvelou V, Breen DP, et al. Reversible cerebral vasoconstriction syndrome as a cause of thunderclap headache: a retrospective case series study. Am J Emerg Med. 2015;33(6):859.e3–6.
   PubMed Web of Science ®Google Scholar
• Zheng VZ, Wong GKC. Neuroinflammation responses after subarachnoid hemorrhage: a review. J Clin Neurosci. 2017; 42:7–11.
   PubMed Web of Science ®Google Scholar
• Sehba FA, Hou J, Pluta RM, et al. The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol. 2012;97(1):14–37.
   PubMed Web of Science ®Google Scholar
• Macdonald RL. Endothelin antagonists in subarachnoid hemorrhage: what next? Crit Care. 2012;16(6):171.
   PubMed Web of Science ®Google Scholar
• Macdonald RL, Higashida RT, Keller E, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10(7):618–625.
   PubMed Web of Science ®Google Scholar
• Macdonald RL, Higashida RT, Keller E, et al. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke. 2012;43(6):1463–1469.
   PubMed Web of Science ®Google Scholar
• Okada T, Suzuki H. Toll-like receptor 4 as a possible therapeutic target for delayed brain injuries after aneurysmal subarachnoid hemorrhage. Neural Regen Res. 2017;12(2):193–196.
   PubMed Web of Science ®Google Scholar
• Kusaka G, Ishikawa M, Nanda A, et al. Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2004;24(8):916–925.
   PubMed Web of Science ®Google Scholar
• Li J, Chen J, Mo H, et al. Minocycline protects against NLRP3 inflammasome-induced inflammation and P53-associated apoptosis in early brain injury after subarachnoid hemorrhage. Mol Neurobiol. 2016;53(4):2668–2678.
   PubMed Web of Science ®Google Scholar
• Fujii M, Yan J, Rolland WB, et al. Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res. 2013;4(4):432–446.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Kawakita F. Tenascin-C in aneurysmal subarachnoid hemorrhage: deleterious or protective?. Neural Regen Res. 2016;11(2):230–231.
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805–820.
   PubMed Web of Science ®Google Scholar
• Schaefer L. Complexity of danger: the diverse nature of damage-associated molecular patterns. J Biol Chem. 2014;289(51):35237–35245.
   PubMed Web of Science ®Google Scholar
• Braza F, Brouard S, Chadban S, et al. Role of TLRs and DAMPs in allograft inflammation and transplant outcomes. Nat Rev Nephrol. 2016;12(5):281–290.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Suzuki H. Possible role of inflammation and galectin-3 in brain injury after subarachnoid hemorrhage. Brain Sci. 2018;8(2):30.
   PubMed Web of Science ®Google Scholar
• Wu L-y, Ye Z-N, Zhuang Z, et al. Biochanin a reduces inflammatory injury and neuronal apoptosis following subarachnoid hemorrhage via suppression of the TLRs/TIRAP/MyD88/NF-kappaB pathway. Behav Neurol. 2018;2018:1–10.
   Web of Science ®Google Scholar
• Buchanan MM, Hutchinson M, Watkins LR, et al. Toll-like receptor 4 in CNS pathologies. J Neurochem. 2010;114(1):13–27.
   PubMed Web of Science ®Google Scholar
• Liu F-y, Cai J, Wang C, et al. Fluoxetine attenuates neuroinflammation in early brain injury after subarachnoid hemorrhage: a possible role for the regulation of TLR4/MyD88/NF-kappaB signaling pathway. J Neuroinflammation. 2018;15(1):347.
   PubMed Web of Science ®Google Scholar
• Wu L-Y, Ye Z-N, Zhou C-H, et al. Roles of pannexin-1 channels in inflammatory response through the TLRs/NF-Kappa B signaling pathway following experimental subarachnoid hemorrhage in rats. Front Mol Neurosci. 2017;10:175.
   PubMed Web of Science ®Google Scholar
• Sun X, Ji C, Hu T, et al. Tamoxifen as an effective neuroprotectant against early brain injury and learning deficits induced by subarachnoid hemorrhage: possible involvement of inflammatory signaling. J Neuroinflammation. 2013;10(1):157.
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhang X-S, Zhang Z-H, et al. Peroxiredoxin 2 activates microglia by interacting with Toll-like receptor 4 after subarachnoid hemorrhage. J Neuroinflammation. 2018;15(1):87.
   PubMed Web of Science ®Google Scholar
• Ma C, Zhou W, Yan Z, et al. Toll-like receptor 4 (TLR4) is associated with cerebral vasospasm and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 2015;55(12):878–884.
   PubMed Web of Science ®Google Scholar
• Matsushima N, Tanaka T, Enkhbayar P, et al. Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors. BMC Genomics. 2007;8(1):124.,
   PubMed Web of Science ®Google Scholar
• Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol. 2004;4(6):469–478.
   PubMed Web of Science ®Google Scholar
• Gay NJ, Gangloff M. Structure and function of toll receptors and their ligands. Annu Rev Biochem. 2007;76(1):141–165.
   PubMed Web of Science ®Google Scholar
• O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in toll-like receptor signalling. Nat Rev Immunol. 2007;7(5):353–364.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ge P, Zhu Y. TLR2 and TLR4 in the brain injury caused by cerebral ischemia and reperfusion. Mediators Inflamm. 2013;2013:1–8.
   Web of Science ®Google Scholar
• Mink M, Fogelgren B, Olszewski K, et al. A novel human gene (SARM) at chromosome 17q11 encodes a protein with a SAM motif and structural similarity to Armadillo/beta-catenin that is conserved in mouse, Drosophila, and Caenorhabditis elegans. Genomics. 2001;74(2):234–244.
   PubMed Web of Science ®Google Scholar
• Kawakita F, Fujimoto M, Liu L, et al. Effects of toll-like receptor 4 antagonists against cerebral vasospasm after experimental subarachnoid hemorrhage in mice. Mol Neurobiol. 2017;54(8):6624–6633.
   PubMed Web of Science ®Google Scholar
• Hanafy KA. The role of microglia and the TLR4 pathway in neuronal apoptosis and vasospasm after subarachnoid hemorrhage. J Neuroinflammation. 2013;10(1):83.
   PubMed Web of Science ®Google Scholar
• Zhang X, Lu Y, Wu Q, et al. Astaxanthin mitigates subarachnoid hemorrhage injury primarily by increasing sirtuin 1 and inhibiting the Toll-like receptor 4 signaling pathway. FASEB J. 2019;33(1):722–737.
   PubMed Web of Science ®Google Scholar
• Kwon M, Woo S, Kurland D, et al. Methemoglobin is an endogenous toll-like receptor 4 ligand-relevance to subarachnoid hemorrhage. IJMS. 2015;16(12):5028–5046.
   Web of Science ®Google Scholar
• Nishikawa H, Liu L, Nakano F, et al. Modified citrus pectin prevents blood-brain barrier disruption in mouse subarachnoid hemorrhage by inhibiting galectin-3. Stroke. 2018;49(11):2743–2751.
   PubMed Web of Science ®Google Scholar
• Xiang-Sheng Z, Wei L, Qi W, et al. Resveratrol attenuates acute inflammatory injury in experimental subarachnoid hemorrhage in rats via inhibition of TLR4 pathway. Int J Mol Sci. 2016;17(8):1331.
   Web of Science ®Google Scholar
• Ma C-X, Yin W-N, Cai B-W, et al. Toll-like receptor 4/nuclear factor-kappa B signaling detected in brain after early subarachnoid hemorrhage. Chin. Med. J. 2009;122(13):1575–1581.
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499–511.
   PubMed Web of Science ®Google Scholar
• Lin SC, Lo YC, Wu H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature. 2010; 465(7300):885–890.
   PubMed Web of Science ®Google Scholar
• Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5:461.
   PubMed Web of Science ®Google Scholar
• Ajibade AA, Wang HY, Wang RF. Cell type-specific function of TAK1 in innate immune signaling. Trends Immunol. 2013;34(7):307–316.
   PubMed Web of Science ®Google Scholar
• Chen ZJ. Ubiquitination in signaling to and activation of IKK. Immunol Rev. 2012;246(1):95–106.
   PubMed Web of Science ®Google Scholar
• Roy A, Srivastava M, Saqib U, et al. Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways. Int Immunopharmacol. 2016;40:79–89.
   PubMed Web of Science ®Google Scholar
• Carty M, Goodbody R, Schröder M, et al. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol. 2006;7(10):1074–1081.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zuo G, Shi X-Y, et al. Progesterone administration modulates cortical TLR4/NF-kappaB signaling pathway after subarachnoid hemorrhage in male rats. Mediators Inflamm. 2011;2011:1–9.
   Web of Science ®Google Scholar
• Wang Z, Wu L, You W, et al. Melatonin alleviates secondary brain damage and neurobehavioral dysfunction after experimental subarachnoid hemorrhage: possible involvement of TLR4-mediated inflammatory pathway. J Pineal Res. 2013; 55(4) :399–408.
   PubMed Web of Science ®Google Scholar
• Zhang T, Su J, Guo B, et al. Ursolic acid alleviates early brain injury after experimental subarachnoid hemorrhage by suppressing TLR4-mediated inflammatory pathway. Int Immunopharmacol. 2014;23(2):585–591.
   PubMed Web of Science ®Google Scholar
• Zhang T, Su J, Guo B, et al. Apigenin protects blood-brain barrier and ameliorates early brain injury by inhibiting TLR4-mediated inflammatory pathway in subarachnoid hemorrhage rats. Int Immunopharmacol. 2015;28(1):79–87.
   PubMed Web of Science ®Google Scholar
• Wang C-X, Xie G-B, Zhou C-h, et al. Baincalein alleviates early brain injury after experimental subarachnoid hemorrhage in rats: possible involvement of TLR4/NF-kappaB-mediated inflammatory pathway. Brain Res. 2015;1594:245–255.
   PubMed Web of Science ®Google Scholar
• Zhou C-h, Wang C-X, Xie G-B, et al. Fisetin alleviates early brain injury following experimental subarachnoid hemorrhage in rats possibly by suppressing TLR 4/NF-kappaB signaling pathway. Brain Res. 2015;1629:250–259.
   PubMed Web of Science ®Google Scholar
• Liu H, Yang M, Pan L, et al. Hyperbaric oxygen intervention modulates early brain injury after experimental subarachnoid hemorrhage in rats: possible involvement of TLR4/NF-x03BA; B-mediated signaling pathway. Cell Physiol Biochem. 2016;38(6):2323–2336.
   PubMedGoogle Scholar
• Wang T-H, Xiong L-L, Yang S-F, et al. LPS pretreatment provides neuroprotective roles in rats with subarachnoid hemorrhage by downregulating MMP9 and caspase3 associated with TLR4 signaling activation. Mol Neurobiol. 2017;54(10):7746–7760.
   PubMed Web of Science ®Google Scholar
• Peng J, Wu Y, Tian X, et al. High-throughput sequencing and co-expression network analysis of lncRNAs and mRNAs in early brain injury following experimental subarachnoid haemorrhage. Sci Rep. 2017;7(1):46577.
   PubMed Web of Science ®Google Scholar
• Xia D-y, Zhang H-S, Wu L-y, et al. Pentoxifylline alleviates early brain injury after experimental subarachnoid hemorrhage in rats: possibly via inhibiting TLR 4/NF-kappaB signaling pathway. Neurochem Res. 2017;42(4):963–974.
   PubMed Web of Science ®Google Scholar
• Yin D, Zhou S, Xu X, et al. Dexmedetomidine attenuated early brain injury in rats with subarachnoid haemorrhage by suppressing the inflammatory response: the TLR4/NF-kappaB pathway and the NLRP3 inflammasome may be involved in the mechanism. Brain Res. 2018;1698:1–10.
   PubMed Web of Science ®Google Scholar
• Liu L, Fujimoto M, Nakano F, et al. Deficiency of tenascin-C alleviates neuronal apoptosis and neuroinflammation after experimental subarachnoid hemorrhage in mice. Mol Neurobiol. 2018;55(11):8346–8354.
   PubMed Web of Science ®Google Scholar
• Okada T, Kawakita F, Nishikawa H, et al. Selective toll-like receptor 4 antagonists prevent acute blood-brain barrier disruption after subarachnoid hemorrhage in mice. Mol Neurobiol. 2019;56(2):976–985.
   PubMed Web of Science ®Google Scholar
• Zhou M-L, Wu W, Ding Y-S, et al. Expression of Toll-like receptor 4 in the basilar artery after experimental subarachnoid hemorrhage in rabbits: a preliminary study. Brain Res. 2007;1173:110–116.
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhao X-D, Zhuang Z, et al. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells. Brain Res. 2010;1322:102–108.
   PubMed Web of Science ®Google Scholar
• Fujimoto M, Suzuki H, Shiba M, et al. Tenascin-C induces prolonged constriction of cerebral arteries in rats. Neurobiol Dis. 2013;55:104–109.
   PubMed Web of Science ®Google Scholar
• Ma Y, Qiao G, Yin Y, et al. Protective effects of astragaloside IV on delayed cerebral vasospasm in an experimental rat model of subarachnoid hemorrhage. World Neurosurg. 2018;118:e443–e448.
   PubMed Web of Science ®Google Scholar
• Zhou M-L, Shi J-X, Hang C-H, et al. Expression of toll-like receptor 4 in the brain in a rabbit experimental subarachnoid haemorrhage model. Inflamm Res. 2007;56(3):93–97.[InsertedFromOnline
   PubMed Web of Science ®Google Scholar
• Sun Q, Dai Y, Zhang X, et al. Expression and cell distribution of myeloid differentiation primary response protein 88 in the cerebral cortex following experimental subarachnoid hemorrhage in rats: a pilot study. Brain Res. 2013;1520:134–144.
   PubMed Web of Science ®Google Scholar
• Sun Q, Wang F, Li W, et al. Glycyrrhizic acid confers neuroprotection after subarachnoid hemorrhage via inhibition of high mobility group box-1 protein: a hypothesis for novel therapy of subarachnoid hemorrhage. Med Hypotheses. 2013;81(4):681–685.
   PubMed Web of Science ®Google Scholar
• Sokol B, et al. Soluble toll-like receptors 2 and 4 in cerebrospinal fluid of patients with acute hydrocephalus following aneurysmal subarachnoid haemorrhage. PLoS One. 2016;11(5):e0156171.
   PubMed Web of Science ®Google Scholar
• Ghaemi A, Alizadeh L, Babaei S, et al. Astrocyte-mediated inflammation in cortical spreading depression. Cephalalgia. 2018;38(4):626–638.
   PubMed Web of Science ®Google Scholar
• Takizawa T, Shibata M, Kayama Y, et al. High-mobility group box 1 is an important mediator of microglial activation induced by cortical spreading depression. J Cereb Blood Flow Metab. 2017;37(3):890–901.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhang Q, Xiong X-Y, et al. TLR4 gene polymorphisms rs11536889 is associated with intracranial aneurysm susceptibility. J Clin Neurosci. 2018;53:165–170.
   PubMed Web of Science ®Google Scholar
• Marbacher S, Fandino J, Kitchen ND. Standard intracranial in vivo animal models of delayed cerebral vasospasm. Br J Neurosurg. 2010;24(4):415–434.
   PubMed Web of Science ®Google Scholar
• Lee J-Y, Sagher O, Keep R, et al. Comparison of experimental rat models of early brain injury after subarachnoid hemorrhage. Neurosurgery. 2009;65(2):331–343. Discussion 343.
   PubMed Web of Science ®Google Scholar
• Titova E, Ostrowski RP, Zhang JH, et al. Experimental models of subarachnoid hemorrhage for studies of cerebral vasospasm. Neurol Res. 2009;31(6):568–581.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wu Q, Zhang Q, et al. Resveratrol attenuates early brain injury after experimental subarachnoid hemorrhage via inhibition of NLRP3 inflammasome activation. Front Neurosci. 2017;11:611.
   PubMed Web of Science ®Google Scholar
• Fadakar K, Dadkhahfar S, Esmaeili A, et al. The role of toll-like receptors (TLRs) in stroke. Rev Neurosci. 2014;25(5):699–712.
   PubMed Web of Science ®Google Scholar
• Fujimoto M, Shiba M, Kawakita F, et al. Deficiency of tenascin-C and attenuation of blood-brain barrier disruption following experimental subarachnoid hemorrhage in mice. JNS. 2016;124(6):1693–1702.
   PubMed Web of Science ®Google Scholar
• van Lieshout JH, Dibué-Adjei M, Cornelius JF, et al. An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage. Neurosurg Rev. 2018;41(4):917–930.
   PubMed Web of Science ®Google Scholar
• Bauer AM, Rasmussen PA. Treatment of intracranial vasospasm following subarachnoid hemorrhage. Front Neurol. 2014;5:72.
   PubMed Web of Science ®Google Scholar
• Ciurea AV, Palade C, Voinescu D, et al. Subarachnoid hemorrhage and cerebral vasospasm - literature review. J Med Life. 2013;6(2):120–125.
   PubMedGoogle Scholar
• Keyrouz SG, Diringer MN. Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care. 2007;11(4):220.
   PubMed Web of Science ®Google Scholar
• Chang CZ, Wu SC, Kwan AL. Glycyrrhizin attenuates toll like receptor-2, -4 and experimental vasospasm in a rat model. J Immunol Res. 2014;2014:1–8.
   Web of Science ®Google Scholar
• Feuerstein GZ, Zaleska MM, Krams M, et al. Missing steps in the STAIR case: a translational medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke. J Cereb Blood Flow Metab. 2008;28(1):217–219.
   PubMed Web of Science ®Google Scholar
• Vergouwen MDI, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391–2395.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Fujimoto M, Kawakita F, et al. Tenascin-C in brain injuries and edema after subarachnoid hemorrhage: findings from basic and clinical studies. J Neurosci Res. 2018;98(1):42–56.
   PubMed Web of Science ®Google Scholar